EATG » Hepatitis

Hepatitis

Pregnant patients with HBV may be assessed via HBV total RNA

In pregnant patients with chronic hepatitis B, hepatitis B virus (HBV) total RNA may help monitor liver disease and viral replication during pregnancy, according to results published in the Journal of…

Many Patients Are Unwilling to Accept Transplantation of an HCV-Positive Organ

The availability of organs that are positive for hepatitis C virus (HCV) can potentially decrease the length of time on organ transplantation waitlists and increase organ availability, but most patients…

Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost

Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in…

Better immune outcomes in HIV/HCV co-infection with DAA regimen

Patients co-infected with HIV and hepatitis C (HCV) may have better outcomes with direct-acting antiviral (DAA) agents compared with patients with HCV mono-infection, according to study findings published in Hepatology Communications In…

Turkmenistan launches its first national strategic plan for viral hepatitis response

Turkmenistan has launched its first-ever national strategic plan on viral hepatitis at a meeting of experts on 20 December 2018 in Ashgabat, Turkmenistan. During the meeting, representatives of the Minister…

Direct-Acting Antivirals Reduce Hepatocellular Carcinoma Risk in Hepatitis C

For patients with chronic hepatitis C virus (HCV) infection, treatment with direct antiviral agents (DAAs) reduces, but does not eliminate, the risk of developing hepatocellular carcinoma (HCC), according to results…

Hepatitis C programmes could save 1.5 million deaths by 2030

Imperial scientists have published the first global estimates to determine the impact of improved prevention, diagnosis and treatment for hepatitis C. A comprehensive package of prevention, screening, and treatment interventions…

Belarus plans to eliminate Hepatitis C transmission in 2-3 years

MINSK, 29 January (BelTA) – Belarus plans to eliminate Hepatitis C transmission in the next two to three years, Yelena Bogdan, the head of the main department of healthcare provision,…

Needle and syringe programmes are highly cost-effective at preventing hepatitis C transmission

Providing clean injecting equipment through needle and syringe programmes is a highly cost-effective way of preventing hepatitis C (HCV) transmission among people who inject drugs and could save millions of…

UK court dismisses AbbVie’s legal challenge against the NHS

AbbVie challenged the mechanism used by the NHS to procure hepatitis C treatment in the biggest procurement deal in NHS history. Talha Burki reports. Download the full report published in…

1 3 4 5 6 7 104